history of glp 1 drugs Historical timeline GLP-1 biology, receptor agonist discovery, and Structural pharmacology and mechanisms of
Description
Am J Health-Syst Pharm
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
Based on the indication, the cardiovascular drugs market is divided into hypertension, hyperlipidemia, coronary artery disease, arrhythmia, and other indications
Government is also stressing better access to leading therapies to reduce disease burden and improve patient care
Amylin agonists: a novel approach in the treatment of diabetes
